Treatment of chemotherapy-induced nausea
Author:
- Rudolph M. NavariRNRudolph M. Navari
- 1 January 2012
- journal article
- Published by Elsevier in Community Oncology
- Vol. 9 (1) , 20-26
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trialSupportive Care in Cancer, 2010
- Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomitingJournal of Experimental & Clinical Cancer Research, 2009
- AprepitantDrugs, 2009
- Pharmacological Management of Chemotherapy-Induced Nausea and VomitingDrugs, 2009
- Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and painExpert Opinion on Investigational Drugs, 2007
- A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group studySupportive Care in Cancer, 2007
- The oral NK1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trialsEuropean Journal of Cancer, 2005
- A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group studySupportive Care in Cancer, 2005
- Delayed emesis: moderately emetogenic chemotherapySupportive Care in Cancer, 2004
- TropisetronDrugs, 2000